gptkbp:instance_of
|
gptkb:virus
|
gptkbp:bfsLayer
|
5
|
gptkbp:bfsParent
|
gptkb:H1_N1
|
gptkbp:caused_by
|
gptkb:swine_flu
|
gptkbp:collaborations
|
necessary
|
gptkbp:community_impact
|
fear and anxiety
|
gptkbp:defense
|
global alert
|
gptkbp:discovered_by
|
gptkb:2009
|
gptkbp:economic_impact
|
disruption
|
gptkbp:end_of_life
|
lower than seasonal flu
|
gptkbp:first_described_by
|
gptkb:Mexico
gptkb:United_States
|
gptkbp:healthcare
|
gptkb:significant
preparedness
reviewed
|
https://www.w3.org/2000/01/rdf-schema#label
|
H1 N1pdm09
|
gptkbp:investment
|
new variants
possible resurgence
|
gptkbp:is_affected_by
|
all age groups
|
gptkbp:is_monitored_by
|
ongoing
|
gptkbp:is_vulnerable_to
|
gptkb:battle
global
rapid
inactivated
live attenuated
|
gptkbp:public_awareness
|
increased
|
gptkbp:research_focus
|
vaccine efficacy
treatment options
viral mutations
|
gptkbp:risk_factor
|
obesity
pregnancy
chronic respiratory conditions
age over 65
age under 5
|
gptkbp:status
|
declared pandemic
|
gptkbp:symptoms
|
fatigue
headache
cough
fever
sore throat
chills
body aches
runny or stuffy nose
|
gptkbp:transmission
|
human-to-human
|
gptkbp:treatment
|
supportive care
antiviral medications
|
gptkbp:variant
|
gptkb:H1_N1
gptkb:H3_N2
gptkb:H5_N1
|